Trump orders more access to psychedelics like psilocybin and ibogaine for federally backed research and controlled therapy

Trump orders new federal efforts to expand research into psychedelics and increase access to drugs like psilocybin in controlled therapeutic settings. The move is presented as a public health and veterans-focused initiative, with military veterans joining Trump to argue the policy could help save lives. The effort targets both scientific study and regulated, clinical availability, framing psychedelics as tools for therapy rather than casual or unrestricted drug use.